Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)Jun Li, Joseph A. Tino, Sean Chen et al.|Journal of Medicinal Chemistry|2010Cited by 41
Design, synthesis and structure–activity relationships of azole acids as novel, potent dual PPAR α/γ agonistsHao Zhang, Peter T. W. Cheng, Denis E. Ryono et al.|Bioorganic & Medicinal Chemistry Letters|2009Cited by 35
BMS-201620: a selective beta 3 agonistWilliam N. Washburn, Andrea A. Seymour, C Sun et al.|Bioorganic & Medicinal Chemistry Letters|2004Cited by 16
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132)Yan Shi, Qi Wang, Wang Ying et al.|Journal of Medicinal Chemistry|2022Cited by 11
Design, synthesis, and structure–activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARα/γ agonistsXiang‐Yang Ye, Peter T. W. Cheng, Yixin Li et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 7